cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.7910/dvn/fiu7zg/cuyiah
title: 114-5_0246.dcm
DOI: 10.7910/dvn/fiu7zg/g4779p
title: 114-1_0047.dcm
DOI: 10.7910/dvn/fiu7zg/ij87ii
title: 114-5_0011.dcm
DOI: 10.7910/dvn/fiu7zg/nsrjci
title: 114-1_0181.dcm
DOI: 10.7910/dvn/fiu7zg/okplpn
title: 114-1_0199.dcm
DOI: 10.7910/dvn/fiu7zg/oupeb9
title: 114-5_0124.dcm
DOI: 10.25934/00001467
title: A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) vs. Butalbital-containing Combination Medications for the Acute Treatment of Migraine When Administered During the Moderate-Severe Migraine Pain, Studies 1 and 2 of 2

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.1467954
title: Nonhuman Primate Reaching With Multichannel Sensorimotor Cortex Electrophysiology: Broadband For Indy_20160915_01

description: This dataset supplements https://doi.org/10.5281/zenodo.583331 .<br>
<br>
<strong>General description.</strong> These data consist of extracellular neural recordings ("broadband") from primate subject "Indy", session identifier "indy_20160915_01".

<strong>Filtering. </strong>The data are sampled at 24414.0625 Hz and are unfiltered, except for an anti-aliasing filter built-in to the recording amplifier: a 4th order low-pass with a roll-off of 24 dB per octave at 7.5 kHz, operating at the sampling rate.

<strong>File format.</strong> The data are contained in an HDF5 formatted file, organized according to the Neurodata Without Borders (NWB) version 1.0.6 specification.

<strong>Datasets. </strong>A few of the relevant dataset paths are listed here for convenience. In the below, <em>n</em> refers to the number of recording channels and <em>k</em> refers to the number of samples.


	"/acquisition/timeseries/broadband/data" - k x n
	
		The broadband neural recordings.
	
	
	"/acquisition/timeseries/broadband/data/conversion" (scalar attribute)
	
		When multiplied by each sample converts the data into units of volts.
	
	
	"/acquisition/timeseries/broadband/timestamps" - k x 1
	
		Timestamps for each sample, seconds.
	
	
	"/general/extracellular_ephys/electrode_map" - n x 3
	
		The relative coordinates of each electrode contact (x, y, z), meters.
	
	


Please refer to the master dataset for further information.
description: This research was supported by the Congressionally Directed Medical Research Program (W81XWH-14-1-0510). JEO was supported by fellowship #2978 from the Paralyzed Veterans of America. JGM was supported by a fellowship from the Swartz Foundation.
DOI: 10.7910/dvn/fiu7zg/7euyv0
title: 114-1_0230.dcm
DOI: 10.7910/dvn/fiu7zg/g2eumw
title: 114-5_0089.dcm
DOI: 10.7910/dvn/fiu7zg/jmvqp6
title: 114-5_0177.dcm
DOI: 10.7910/dvn/fiu7zg/p86bsz
title: 114-1_0095.dcm
DOI: 10.7910/dvn/fiu7zg/pbokfd
title: 114-5_0104.dcm
DOI: 10.7910/dvn/fiu7zg/pyj4le
title: 114-5_0220.dcm
DOI: 10.7910/dvn/fiu7zg/sxpvyx
title: 114-1_0012.dcm
DOI: 10.7910/dvn/fiu7zg/uduarn
title: 114-1_0133.dcm
DOI: 10.25934/00000573
title: Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) - A Placebo-controlled, Single-Blind Comparative Study -

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001479
title: A Randomized, Double Blind Comparator-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 and Atorvastatin 20 mg vs Atorvastatin Monotherapy in Subjects With Moderate Hypercholesterolemia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.3886/e106966v1
title: Illustration of measurement error models for reducing biases in nutrition and obesity research using 2D body composition data
DOI: 10.5281/zenodo.1473701
title: Test Phenology Annotations From Herbarium Specimen Dataset - Prunus Serotina

description: This is a test dataset of phenology annotations for the Black Cherry, P.  serotina, used in the submitted manuscript:

Brenskelle, L., B. Stucky, J. Deck, R. Walls, R. P. Guralnick [submitted].  Integrating herbarium specimen observations into global phenology data systems.  Applications in Plant Sciences.
DOI: 10.5281/zenodo.1473702
title: Test Phenology Annotations From Herbarium Specimen Dataset - Prunus Serotina

description: This is a test dataset of phenology annotations for the Black Cherry, P.  serotina, used in the submitted manuscript:

Brenskelle, L., B. Stucky, J. Deck, R. Walls, R. P. Guralnick [submitted].  Integrating herbarium specimen observations into global phenology data systems.  Applications in Plant Sciences.
DOI: 10.7910/dvn/fiu7zg/3zhmgj
title: 114-1_0117.dcm
DOI: 10.7910/dvn/fiu7zg/4ewvy4
title: 114-5_0227.dcm
DOI: 10.7910/dvn/fiu7zg/aagj5i
title: 114-5_0178.dcm
DOI: 10.7910/dvn/fiu7zg/fogldo
title: 114-5_0100.dcm
DOI: 10.7910/dvn/fiu7zg/lm280h
title: 114-1_0049.dcm
DOI: 10.7910/dvn/fiu7zg/ners0v
title: 114-1_0071.dcm
DOI: 10.7910/dvn/fiu7zg/ublrka
title: 114-5_0092.dcm
DOI: 10.7910/dvn/fiu7zg/wklhce
title: 114-1_0188.dcm
DOI: 10.7910/dvn/fiu7zg/ywzx2z
title: 114-5_0160.dcm
DOI: 10.25934/00001482
title: A Double-blind, Randomised, Multiple Dose, Phase III, Multicentre Study of Alpharadin in the Treatment of Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002456
title: A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/7wqldc
title: 114-1_0216.dcm
DOI: 10.7910/dvn/fiu7zg/8bkc7y
title: 114-1_0175.dcm
DOI: 10.7910/dvn/fiu7zg/a3t9cq
title: 114-5_0079.dcm
DOI: 10.7910/dvn/fiu7zg/caiq89
title: 114-5_0041.dcm
DOI: 10.7910/dvn/fiu7zg/dogg4r
title: 114-5_0057.dcm
DOI: 10.7910/dvn/fiu7zg/hqwblw
title: 114-1_0031.dcm
DOI: 10.7910/dvn/fiu7zg/iqpzoh
title: 114-5_0200.dcm
DOI: 10.7910/dvn/fiu7zg/q7jbr9
title: 114-1_0204.dcm
DOI: 10.7910/dvn/fiu7zg/s908id
title: 114-5_0112.dcm
DOI: 10.25934/00001492
title: A Phase III, Long Term, Open Label, Follow on Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor 'Lomitapide' (LOMITAPIDE) in Patients With Homozygous Familial Hypercholesterolemia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/8o4yvq
title: 114-5_0029.dcm
DOI: 10.7910/dvn/fiu7zg/8qkiby
title: 114-1_0186.dcm
DOI: 10.7910/dvn/fiu7zg/buyvru
title: 114-5_0156.dcm
DOI: 10.7910/dvn/fiu7zg/damx3h
title: 114-5_0002.dcm
DOI: 10.7910/dvn/fiu7zg/gz7hjj
title: 114-1_0123.dcm
DOI: 10.7910/dvn/fiu7zg/jq1hy6
title: 114-1_0139.dcm
DOI: 10.7910/dvn/fiu7zg/lbhfrv
title: 114-5_0054.dcm
DOI: 10.7910/dvn/fiu7zg/r8uel5
title: 114-5_0234.dcm
DOI: 10.7910/dvn/fiu7zg/tvidft
title: 114-1_0116.dcm
DOI: 10.17632/fcngmddspx.1
title: Supplementary data to Sarabeev, V.L., Balbuena, J.A., Morand, S. Aggregation patterns of helminths populations in the introduced fish, Liza haematocheilus (Teleostei: Mugilidae): disentangling host-parasite relationships. Int. J. Parasitol.

description: The data file contains Supplementary Tables S1 and S2.
DOI: 10.17632/vthcx7gztw.1
title: Decomposing the composite face effect

description: These data were produced from a composite face experiment.
DOI: 10.25499/srhy6x4pv9crvbp9wqckpc7oo
title: Submitted chemical data for InChIKey BSYNRYMUTXBXSQ-UHFFFAOYSA-N
DOI: 10.25934/00000602
title: Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age (Co-administered With Infanrix®) in Primed Healthy Toddlers.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/0ujbon
title: 114-5_0214.dcm
DOI: 10.7910/dvn/fiu7zg/6uu38y
title: 114-1_0086.dcm
DOI: 10.7910/dvn/fiu7zg/a3wfkj
title: 114-5_0068.dcm
DOI: 10.7910/dvn/fiu7zg/cxtdul
title: 114-1_0106.dcm
DOI: 10.7910/dvn/fiu7zg/fijgxg
title: 114-1_0080.dcm
DOI: 10.7910/dvn/fiu7zg/uhvfvh
title: 114-5_0102.dcm
DOI: 10.7910/dvn/fiu7zg/xsd5l1
title: 114-5_0000.dcm
DOI: 10.17632/r2n6xdwgzk.1
title: Mind Research Network/MIND Clinical Imaging Consortium (MRN/MCIC) dataset

description: Dataset containing subjects who performed the Sternberg Item Recognition Paradigm (SIRP) on three difficulties (1- easy, 2-medium, 3-hard) in a block-design experiment. each subject's SPM.mat discloses the variables collected during the experiment.
DOI: 10.17632/s294p9sf9r.2
title: MALDI-TOF normalized average mass spectra of Escherichia coli treated by essential oil components, chlorine, proxide and tetracyckline

description: This dataset contains normalized spectra of Escherichia coli. The E. coli culture was treated with chemical agents derived from essential oils and subsequently measured by the MALDI-TOF at 30, 60, 90 and 120 minutes after treatment. Methods are described in the article. Exported spectra are in TXT files (m/z and intensity) for processing in other software (ex. mMass).
DOI: 10.25934/00001508
title: A Phase II Open Label, Dose-Escalation Study to Determine the Safety, Tolerability and Efficacy of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor BMS-201038 in Patients With Homozygous Familial Hypercholeterolemia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001510
title: A Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Lomitapide in Japanese and Caucasian Volunteers With Elevated Low-density-lipoprotein(LDL-C)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/3g0khj
title: 114-1_0073.dcm
DOI: 10.7910/dvn/fiu7zg/bren4o
title: 114-1_0055.dcm
DOI: 10.7910/dvn/fiu7zg/gvrg4d
title: 114-5_0203.dcm
DOI: 10.7910/dvn/fiu7zg/i4istu
title: 114-1_0058.dcm
DOI: 10.7910/dvn/fiu7zg/jgrhj7
title: 114-5_0043.dcm
DOI: 10.7910/dvn/fiu7zg/mf26ag
title: 114-5_0075.dcm
DOI: 10.7910/dvn/fiu7zg/ntpqdp
title: 114-1_0022.dcm
DOI: 10.7910/dvn/fiu7zg/uqlcgz
title: 114-5_0046.dcm
DOI: 10.7910/dvn/fiu7zg/xzkl7n
title: 114-1_0164.dcm
DOI: 10.7910/dvn/fiu7zg/yrkrrm
title: 114-1_0229.dcm
DOI: 10.17632/5y2t4mkjbv.1
title: A three year time-series of volatile organic iodocarbons in Bedford Basin, Nova Scotia: a Northwestern Atlantic fjord

description: weekly observation of iodocarbons and other physic and biologic parameters
DOI: 10.17632/b38w5429rg.1
title: USM dataset (first third) Locally Linear Embedding and fMRI feature selection for psychiatric classification

description: first third of ABIDE dataset collected at the Utah School of Medicine ("USM")
DOI: 10.17632/xp9cwv6mpb.1
title: Data for: Plasmonic Nanoparticle-based Epoxy Photocuring

description: Contents Appendix A. Electromagnetic simulations Appendix B. Heat Transfer simulations Appendix C. Influence of parameters Appendix D. Aluminum nanoparticles: practicality and stacking effects Appendix E. Bond strength with no nanoparticles References
DOI: 10.25934/00001512
title: A Phase 1, Open-label, Crossover Study to Determine the Intra-subject Variability of the Pharmacokinetics of Single Oral CapsuleDose of 20 mg Lomitapide in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001516
title: A Phase 1, Open-label, Randomised, Crossover Study to Determine the Comparative Bioavailability of 20 mg Lomitapide Where the Contents Have Been Opened and Sprinkled in Applesauce or Mashed Banana ("Sprinkled Contents") to a Single Oral Capsule Dose of 20 mg Lomitapide ("Intact Capsule") in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001518
title: A Phase 1, Open-Label, Randomized, 2-Arm Study to Evaluate the Effect of Atorvastatin, a Weak CYP3A4 Inhibitor, on the Pharmacokinetics of Lomitapide in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001519
title: A Phase 1, Open-Label, Randomized, 2-Arm Study to Evaluate the Effect of Ethinyl Estradiol/Norgestimate (Ortho Cyclen®), a Weak CYP3A4 Inhibitor, on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00001520
title: A Phase 3, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Lomitapide in Japanese Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Concurrent Lipid-Lowering Therapy

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/cfdrdh
title: 114-1_0218.dcm
DOI: 10.7910/dvn/fiu7zg/gmiozz
title: 114-1_0051.dcm
DOI: 10.7910/dvn/fiu7zg/nziq5g
title: 114-1_0018.dcm
DOI: 10.7910/dvn/fiu7zg/tusqq0
title: 114-5_0198.dcm
DOI: 10.7910/dvn/fiu7zg/v1vxi4
title: 114-1_0157.dcm
DOI: 10.7910/dvn/fiu7zg/wweyai
title: 114-1_0193.dcm
DOI: 10.7910/dvn/fiu7zg/wzcqfo
title: 114-5_0131.dcm
DOI: 10.7910/dvn/fiu7zg/xkemxa
title: 114-5_0139.dcm
DOI: 10.17632/krnpyx28rk.1
title: Sustainability Indicators: Review Organization Database

description: The categories, indicators and units represented in this dataset are derived from the final 40 papers that were deemed appropriate for categorization using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) method to represent relevant sustainability indicators within the manufacturing, materials, and biomass industries under the four pillars of sustainability (environment, economic, social and technical) in their entirety. Although certain indicators exhibited several overlaps between pillars (e.g., socio-economic, techno-economic, enviro-socio-economic), these indicators have been restricted to one pillar and one category each to better understand their place within these disciplines and pillars—and avoid double counting. A database was created in Microsoft Access such that each indicator could be thoroughly reviewed and sorted to ensure its appropriateness to the respective category, check for gaps in data, and fill them accordingly. The complete Access database can be found here describing. The discussion and reasoning for categorization can be found within the accompanying manuscript submitted for consideration for publication.
DOI: 10.17632/np69ms23kb.1
title: cephalometric measurements closely associated with the facial profile esthetics of skeletal Class Ⅲ malocclusion after treatment

description: Esthetic degrees of each Class Ⅲ patients’ facial profiles after surgical-orthodontic or camouflage treatment were different,some cephalometric measurements may be correlated with the degree of profile esthetics in skeletal Class Ⅲ malocclusion.Esthetic degrees of 237 Class Ⅲ patients’ facial profiles after surgical-orthodontic or camouflage treatment were evaluated by 9 orthodontists. We defined the top and bottom 40 patients posttreatment for esthetics as the high-score and low-score groups, respectively,to analyze the differences in 22 between the groups. Logistic regression analysis was performed for the measurements with significant differences between the groups to determine which is correlated with the profile esthetic degree
DOI: 10.17632/pmtp6zn3ny.2
title: Database: Uncovering investment management performance using SPIVA data

description: We used balanced panel data with 17 time dimensions from 2000 to 2016 and 14 cross sections (representing the different fund style/size categories) from the SPIVA US Scorecard, resulting in a total of 238 observations. The datasets of SPIVA scorecards only starts from 2000 as no data available for pre-2000 period. data is collected from the SPIVA US mid-year 2010 to the SPIVA US year-end 2016 reports, giving us semi-annual data from 12 SPIVA scorecards. The reason for using this time period is that the mid-year 2010 scorecard was the earliest one that is publicly available on the Standard and Poor’s website (Standard and Poor’s, 2017).
DOI: 10.17632/vr8yvz54df.1
title: USM dataset (second third) Locally Linear Embedding and fMRI feature selection for psychiatric classification

description: second third of ABIDE dataset collected at the Utah School of Medicine ("USM")
DOI: 10.18113/d3g37f
title: Prevalence and risk factors for bovine tuberculosis in West Bengal, India
DOI: 10.25934/00000626
title: Immunogenicity  Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 Administered in Healthy Subjects Either Previously Primed With Mencevax™ ACWY or naïve to Meningococcal Vaccination.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00000628
title: Non-inferiority of GSK Biologicals' Meningococcal Vaccine (GSK134612) Compared to Licensed MenC-CRM197 Conjugate Vaccine in Healthy Children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.7910/dvn/fiu7zg/cloqlb
title: 114-1_0044.dcm
DOI: 10.7910/dvn/fiu7zg/dhitib
title: 114-1_0115.dcm
DOI: 10.7910/dvn/fiu7zg/fywwdd
title: 114-5_0151.dcm
DOI: 10.7910/dvn/fiu7zg/gww5bb
title: 114-1_0242.dcm
DOI: 10.7910/dvn/fiu7zg/vbkdsa
title: 114-5_0025.dcm